首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1424424

全球藥品銷售外包市場：按服務類型、按治療領域、按最終用戶、按地區

Global Pharmaceutical Contract Sales Outsourcing Market, By Service Type, By Therapeutic Area, By End User, By Geography

出版日期: 2024年01月12日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球醫藥合約外包 (CSO) 市場規模預計將從 2023 年的 85.992 億美元增至 2030 年的 153.467 億美元，預測期內複合年成長率為 8.6%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	85.992 億美元
實際資料	2018-2021	預測期	2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率：	8.60%	2030/2031價值預測	153.467 億美元

圖 1. 2023 年按地區分類的藥品銷售合約外包 (CSO) 的全球市場佔有率(%)

近年來，全球醫藥合約外包（CSO）市場呈現出良好的成長動能。為了專注於藥物研發，製藥商擴大將銷售和行銷業務委託給專業的 CSO 供應商。 CSO 公司協助製藥商最佳化銷售業務、管理代理商拜訪並確保促銷符合監管指南。公民社會組織利用資料驅動的主導和技術解決方案來提高銷售負責人的效率並擴大醫生的覆蓋範圍。外包模式使製藥公司能夠獲得專業知識並提高業務效率，而不會產生高昂的固定成本。這種具有成本效益的方法在尋求簡化商業化活動的生物製藥公司中越來越受歡迎。

市場動態：.

全球製藥合約外包（CSO）市場是由生物製藥公司最佳化營運成本和提高生產力的需求等因素推動的。此外，藥品促銷法規日益複雜（尤其是在美國），導致製藥公司將其銷售業務外包給熟悉合規框架的專業 CSO 提供者。此外，客戶關係管理和資料分析的技術進步正在增加對外包銷售業務的需求。然而，藥品價格環境的波動以及部分地區醫療改革的不利為市場主體帶來了挑戰。此外，CSO 產業形勢的整合也會影響顧客關係。新的商機在於擴展到非傳統治療領域並提供附加價值服務。

公司對簡化銷售流程和提高效率的需求不斷成長，可能會進一步推動對銷售計劃/績效分析軟體的需求。例如，2023 年 11 月 7 日，數位科技公司Accenture和軟體公司銷售團隊 Inc. 宣布合作，為生命科學公司建立由人工智慧 (AI) 驅動的雲端服務。透過此次合作，Accenture將把生物醫學研究產業和人工智慧技術的獨特專業知識添加到銷售團隊的生命科學雲中，創建新軟體，幫助醫療技術、生物技術和製藥公司提高效率。我們將為實現我們的目標做出貢獻。使命。

本研究的主要特點

本報告對全球藥品合約外包（CSO）市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年成長率。
它確定了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球合約銷售業務(CSO) 市場的主要企業進行了分析。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球合約銷售業務(CSO) 市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過在分析全球藥品分銷外包 (CSO) 市場時使用的各種策略矩陣來促進決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第9章競爭形勢

公司簡介
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company（TMAC）
- Ashfield Healthcare Communications Group
- GTS Solutions

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6549

The global pharmaceutical contract sales outsourcing (CSO) market size is expected to reach US$ 15,346.7 Mn by 2030, from US$ 8,599.2 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.6% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 8,599.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.60%	2030/2031 Value Projection:	US$ 15,346.7 Mn

Figure 1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share (%), By Region, 2023

Global Pharmaceutical Contract Sales Outsourcing Market - IMG1

The global pharmaceutical contract sales outsourcing (CSO) market has shown promising growth in recent years. Pharmaceutical manufacturers are increasingly outsourcing their sales and marketing operations to specialized CSO providers in order to focus on drug research and development. CSO firms assist drug makers in optimizing sales operations, managing representative visits, and ensuring promotional compliance with regulatory guidelines. They leverage data-driven insights and technological solutions to enhance sales representative effectiveness and expand physician reach. The outsourcing model enables pharmaceutical companies to access specialized expertise and achieve operational efficiencies without incurring high fixed costs. This cost-effective approach has thus gained traction among biopharma firms looking to streamline commercialization activities.

Market Dynamics:

The global pharmaceutical contract sales outsourcing (CSO) market is driven by factors such as the need of biopharma players to optimize sales costs and boost productivity. Growing complexity of drug promotion regulations particularly in the U.S. also prompts pharmaceutical companies to outsource sales operations to specialized CSO providers well-versed with compliance frameworks. Additionally, technological advancements in customer relationship management and data analytics are translating into increased demand for outsourced sales capabilities. However, volatility in drug pricing environments and unfavorable healthcare reforms in certain regions pose challenges to market players. Furthermore, consolidation in the CSO industry landscape impacts client relationships. Emerging opportunities lie in expansion into non-traditional therapeutic areas and offering value-added services around market access.

Increasing requirement for companies to streamline the sales process and achieve higher efficiency will further aid in the demand for sales planning/performance analytics software. For instance, on November 7, 2023, Accenture, a digital technology company, and Salesforce, Inc., a software company, announced the collaboration to build an Artificial intelligence (AI) powered cloud service for life sciences companies. Under the collaborations, Accenture added its own expertise both in the biomedical research industry and in artificial intelligence technologies to the Salesforce Life Sciences Cloud to help fulfill the new software's mission of making medtech, biotech, and pharma companies more efficient.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical contract sales outsourcing (CSO) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical contract sales outsourcing (CSO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical contract sales outsourcing (CSO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical contract sales outsourcing (CSO) market

Detailed Segmentation:

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type
- Personal Promotion
- Non-personal Promotion
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area
- Cardiovascular Disorders
- Oncology
- Metabolic Disorders
- Neurology
- Orthopedic Diseases
- Infectious Diseases
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User
- Biopharmaceutical Companies
- Medical Device Companies
- Generic Companies
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Top Companies in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market:
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company (TMAC)
- Ashfield Healthcare Communications Group
- GTS Solutions

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Digital technology adoption
- Access to care disparities
- Population health initiatives
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Non-personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Orthopedic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Generic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
North Africa
Central Africa
South Africa